As We Age: Considering the Impact of Renal Impairment When Choosing an HIV Pre-Exposure Prophylaxis (PrEP) Formulation

Lack of knowledge about PrEP remains a major barrier for optimal PrEP uptake. Furthermore, knowledge of PrEP and long-term risk mitigation related to renal impairment and use in individuals with medical comorbidities is necessary for improving widespread uptake. This is particularly important in aging individuals who are at risk for contracting HIV, as they may have medical comorbidities and risk factors that will impact treatment decisions.

This CME Outfitters BriefCase will introduce Matthew, a 53-year-old Hispanic man who has type 2 diabetes and hypertension who originally dismissed HIV prevention strategies but after considering the risk and consequences of HIV infection is now open to discussion. This patient case will be used to highlight how best to engage older adults who are at risk for contracting HIV in discussions about HIV prevention strategies, including assessing and applying clinical trial data to decision-making for PrEP initiation.

At the end of this CME/CE activity, participants should be able to:
- Apply clinical trial data and other available evidence to decision making for initiation of PrEP.